FDA pharmacologic class
ACE inhibitors
11 medicines are in FDA's class of angiotensin converting enzyme inhibitors (ACE inhibitors): lisinopril (Zestril), enalapril (Vasotec), benazepril (Lotensin), ramipril, captopril, quinapril, fosinopril, trandolapril and 3 more; 8 combination products also contain one. All 19 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is lisinopril 20 mg tablet at $0.0254 per tablet (NADAC).
Which medicines are ace inhibitors?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Lisinopril | Zestril, Qbrelis | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry | 28 |
| Enalapril | Vasotec, Epaned | 28 labelers | $0.0664 per tablet 10 mg tablet | Yes | No current entry | 17 |
| Hydrochlorothiazide and lisinopril | Zestoretic | 27 labelers | $0.0293 per tablet 10-12.5 mg tablet | Yes | No current entry | 7 |
| Amlodipine and benazepril | none listed | 16 labelers | $0.114 per unit 10-20 mg | Yes | No current entry | 8 |
| Benazepril | Lotensin | 21 labelers | $0.0789 per tablet 20 mg tablet | Yes | No current entry | 1 |
| Ramipril | none listed | 17 labelers | $0.0707 per capsule 10 mg capsule | Yes | No current entry | 5 |
| Captopril | none listed | 13 labelers | $0.228 per tablet 12.5 mg tablet | Yes | No current entry | 5 |
| Quinapril | none listed | 9 labelers | n/a | Yes | In shortage | 7 |
| Benazepril and hydrochlorothiazide | Lotensin | 3 labelers | $0.222 per tablet 20-12.5 mg tablet | Yes | No current entry | 0 |
| Fosinopril | none listed | 7 labelers | $0.154 per tablet 10 mg tablet | Yes | No current entry | 3 |
| Trandolapril | none listed | 5 labelers | $0.157 per tablet 1 mg tablet | Yes | No current entry | 0 |
| Hydrochlorothiazide and quinapril | none listed | 4 labelers | n/a | Yes | In shortage | 4 |
| Moexipril | none listed | 3 labelers | $1.00 per tablet 15 mg tablet | Yes | No current entry | 1 |
| Enalapril and hydrochlorothiazide | Vaseretic | 2 labelers | $0.209 per tablet 10-25 mg tablet | Yes | No current entry | 2 |
| Enalaprilat | none listed | 3 labelers | n/a | Yes | No current entry | 0 |
| Captopril and hydrochlorothiazide | none listed | 1 labeler | n/a | Yes | No current entry | 0 |
| Fosinopril and hydrochlorothiazide | none listed | 2 labelers | $0.634 per tablet 10-12.5 mg tablet | Yes | No current entry | 1 |
| Trandolapril and verapamil | none listed | 1 labeler | n/a | Yes | No current entry | 1 |
| Perindopril | none listed | 1 labeler | $0.495 per tablet 4 mg tablet | Yes | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price